leadf
logo-loader
viewHeritage Cannabis Holdings Corp.
(
CSE:CANNOTCQX:HERTF
)

Heritage Cannabis receives cannabis research licence from Health Canada

The licence will allow Heritage to conduct research, analysis and trials for the assessment and development of its portfolio of differentiated medical and recreational cannabis products

Heritage Cannabis Holdings Corp. -
The company said the licence is an "exciting milestone" as it prepares to launch its products and brands in the US market

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) (FRA:2UE) announced  its wholly-owned Voyage Cannabis Corp subsidiary has received its cannabis research licence under Health Canada’s Cannabis Act and Cannabis Regulations.

Heritage said the licence will allow it to conduct research, analysis and trials for the assessment and development of its growing portfolio of differentiated medical and recreational cannabis products. 

“At Heritage we are at the forefront of product innovation and providing recreational and medical cannabis consumers with products they want. Our innovation team now has the competitive advantage it needs to continue to employ best practices in product evaluation, and tailor products that complement our already popular line of extracts and extract derivatives,” Heritage Cannabis Holdings CEO Clint Sharples said in a statement.

READ: Heritage Cannabis acquires recreational cannabis group Bloom Brands 

“This is an exciting milestone for Heritage as we prepare to launch our products and brands in the US market following the completion of our recently announced acquisition of Bloom Brands in the US,” Sharples added.

The company also noted that it hopes to use the licence to conduct controlled trials of its cannabis extracts, concentrates and oils, including vaporizers, topicals, beverages and edible products, operating from its extraction and manufacturing facility in Falkland, British Columbia, subject to the conditions outlined by Health Canada.   

Heritage Cannabis is a vertically integrated cannabis provider that currently has two Health Canada-approved licensed producers, through its subsidiaries Voyage Cannabis Corp and CannaCure Corp, both of which are regulated under the Cannabis Act Regulations. 

The company recently acquired Canadian recreational and medical cannabis company Premium 5 Ltd, which Heritage Cannabis expects will make it a leader in the extract and extract derivatives market, as Premium 5 is a premium provider of Cannabis 2.0 hydrocarbon and solventless concentrates in Canada.

Contact Sean at sean@proactiveinvestors.com

Quick facts: Heritage Cannabis Holdings Corp.

Follow
CSE:CANN

Price: 0.07 CAD

Market Cap: $54.81 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Heritage Cannabis sets new monthly record with 3.2 million dollars in sales

Heritage Cannabis CEO David Schwede joined Steve Darling from Proactive to share news the company is continuing to set records in sales. Unaudited sales for July, 2021 saw a monthly record of $3.2-million dollars. That marks the 5th monthly sales record in 2021. Schwede telling Proactive the...

on 24/8/21

2 min read